Unimed Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.83 M
as on 16-11-2024
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 130.00 Cr
as on 16-11-2024
- Revenue 6.06%
(FY 2023)
- Profit 532.81%
(FY 2023)
- Ebitda 454.13%
(FY 2023)
- Net Worth 11.35%
(FY 2023)
- Total Assets -31.22%
(FY 2023)
About Unimed Technologies
The Corporate was formerly known as Milmet Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.83 M.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹130.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kailash Sankhlecha, Kulvir Kadwadkar, and Darshna Mehta serve as directors at the Company.
- CIN/LLPIN
U24230GJ1997PLC031523
- Company No.
031523
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jan 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Panch Mahals, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Unimed Technologies Limited. offer?
Unimed Technologies Limited. offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API.
Who are the key members and board of directors at Unimed Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kailash Sankhlecha  | Director | 29-Sep-2009 | Current |
| Darshna Mehta | Director | 18-Jan-2016 | Current |
| Kulvir Kadwadkar | Director | 28-Mar-2009 | Current |
Financial Performance and Corporate Structure Insights of Unimed Technologies.
Unimed Technologies Limited., for the financial year ended 2023, experienced modest growth in revenue, with a 6.06% increase. The company also saw a substantial improvement in profitability, with a 532.81% increase in profit. The company's net worth Soared by an impressive increase of 11.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unimed Technologies?
In 2023, Unimed Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Winstar Mercantile Company Private LimitedActive 18 years 11 months
Darshna Mehta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indusind Bank Ltd. Creation Date: 01 Apr 2014 | ₹10.00 Cr | Open |
Indusind Bank Ltd. Creation Date: 02 Feb 2015 | ₹130.00 Cr | Satisfied |
How Many Employees Work at Unimed Technologies?
Unimed Technologies has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimed Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimed Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
